<DOC>
	<DOCNO>NCT00859014</DOCNO>
	<brief_summary>The purpose research study find bone marrow treatment ( bone marrow aspiration infusion stem cell ) safely use adult recently ( within 24-72 hour ) suffer acute ischemic stroke .</brief_summary>
	<brief_title>Safety/Feasibility Autologous Mononuclear Bone Marrow Cells Stroke Patients</brief_title>
	<detailed_description>Our primary hypothesis autologous bone marrow mononuclear cell transplantation intravenous administration feasible safe acute ischemic stroke . Our secondary hypothesis autologous transplantation associate improved outcome acute stroke .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>1. acute ischemic stroke 2. age 18 83 year If &gt; 80 prestroke mRS need &lt; 1 ) 3 . Right hemisphere NIHSS 6 15 , leave hemisphere NIHSS 618 4. know onset time acute symptom 5. stem cell transplantation procedure must perform within 24 72 hr stroke symptom onset 6 . TPA infusion allow 1 . NIHSS 1a &gt; 1 2. prestroke mRS &gt; 1 &gt; 80 year age 3 . Ischemic stroke last 3 month , vascular territory 4 . MI , primary hemorrhagic traumatic lesion brain within last 3 month identify MRI . Small hemorrhagic transformation acute infarct allow . 5. seizure disorder 6. developmental delay 7. chronic kidney disease define baseline creatinine &gt; 1.4 8. hepatic disease alter liver function define SGPT &gt; 150 U/L T. Bilirubin &gt; 1.6 mg/dL admission 9. pulmonary disease ( e.g , COPD oxygenrequirement rest ambulation , moderate severe asthma ) 10. mechanical heart valve 11 . Active malignancy diagnosis malignancy within 5 year prior start screen history chemotherapy radiation affect bone marrow . Skin cancer ( except melanoma ) permit . 12. prior immunosuppression , include chemotherapy administration within last 3 year current immunosuppression define WBC &lt; 3 x 103 cells/ml 13. know HIV 14. hemoglobin &lt; 10g/dl 15. uncorrected coagulopathy time consent define INR &gt; 1.4 ; PTT &gt; 37 sec , thrombocytopenia ( PLT &lt; 100,000 ) 16. hemodynamic instability time consent ( e.g , require continuous fluid resuscitation ionotropic support ) . 17 . Hypoxemia ( SaO2 &lt; 90 % ) time consent , respiratory distress persistent hypoxemia define SaO2 &lt; 94 % &gt; 30 minute occur time hospital admission time consent . Intubation alone exclusion . 18. pregnancy positive bHCG 19. current participation interventional research study 20. unable return followup visit clinical evaluation , laboratory study , image evaluation 21 . Multiple antiplatelet medication ( Aggrenox consider single platelet agent ) 22 . Unable undergo MRI CT scan 23 . Any condition investigator feel would pose significant hazard patient enrol . 24 . Exclude infarct lesion size &gt; 145cc unless NIHSS 1a remain &lt; 1 evidence infarct expansion edema formation image obtain admission point prior infusion . 25 . Exclude IA therapy use plan anticipated hemicraniectomy . Diagnostic angiogram allow 26 . CT and/or Multimodal MRI exclusion criterion : hemispheric stroke &lt; 1.5 cm maximum diameter ( MRI see diffusionweighted image CT ) midline shift &gt; 1mm significant hemorrhagic transformation acute infarct</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>83 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>